Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. (ALNY) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ALNY · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
418
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Alnylam Pharmaceuticals, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ALNY insider buying and selling by quarter
ALNY insider selling · ALNY insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ALNY ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ALNY executive sell shares · ALNY board member insider trading · ALNY insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 1, 2026 | PYOTT DAVID E I Director | Option | 3,830 | — | Form 4 |
| Jun 1, 2026 | PYOTT DAVID E I Director | Sale | 921 | $274K | Form 4 |
| Jun 1, 2026 | PYOTT DAVID E I Director | Sale | 1,175 | $351K | Form 4 |
| Jun 1, 2026 | PYOTT DAVID E I Director | Sale | 1,222 | $366K | Form 4 |
| Jun 1, 2026 | PYOTT DAVID E I Director | Sale | 495 | $149K | Form 4 |
| Jun 1, 2026 | PYOTT DAVID E I Director | Sale | 17 | $5K | Form 4 |
| May 20, 2026 | Sigal Charles Elliott Director | Award | 671 | — | Form 4 |
| May 20, 2026 | SCHULMAN AMY W Director | Award | 838 | — | Form 4 |
| May 20, 2026 | Reitan Colleen F Director | Award | 671 | — | Form 4 |
| May 20, 2026 | PYOTT DAVID E I Director | Award | 671 | — | Form 4 |
| May 20, 2026 | KELLOGG PETER N Director | Award | 671 | — | Form 4 |
| May 20, 2026 | HAMBURG MARGARET A Director | Award | 671 | — | Form 4 |
| May 20, 2026 | BRANDICOURT OLIVIER Director | Award | 671 | — | Form 4 |
| May 20, 2026 | Ausiello Dennis A Director | Award | 671 | — | Form 4 |
| May 20, 2026 | Arbuckle Stuart A Director | Award | 671 | — | Form 4 |
| May 13, 2026 | SCHULMAN AMY W Director | Option | 11,250 | $790K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 265 | $84K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 359 | $114K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 209 | $67K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 86 | $27K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 147 | $47K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 224 | $72K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 245 | $79K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 81 | $26K | Form 4 |
| Apr 2, 2026 | McLaughlin Melissa Chief Human Resources Officer | Sale | 8 | $3K | Form 4 |
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
265
Price
$316.61
Value
$84K
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
359
Price
$317.44
Value
$114K
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
209
Price
$318.47
Value
$67K
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
86
Price
$319.69
Value
$27K
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
147
Price
$320.62
Value
$47K
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
224
Price
$321.64
Value
$72K
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
245
Price
$322.86
Value
$79K
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
81
Price
$323.64
Value
$26K
McLaughlin Melissa
Chief Human Resources Officer
Date
Apr 2
Shares
8
Price
$325.49
Value
$3K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ALNY insider trading
ALNY insider trades
Alnylam Pharmaceuticals, Inc. (ALNY) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Poulton Jeffrey V. (EVP, Chief Financial Officer), McLaughlin Melissa (Chief Human Resources Officer), Garg Pushkal (EVP Chief R&D). Over the past 12 months, 5 insiders have filed transactions with the SEC. ALNY insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Alnylam Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ALNY insider trading · 5 questionsThe insiders of Alnylam Pharmaceuticals, Inc. (ALNY) include executives and directors such as Poulton Jeffrey V. (EVP, Chief Financial Officer), McLaughlin Melissa (Chief Human Resources Officer), Garg Pushkal (EVP Chief R&D), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026